Soliqua 100/33 (insulin glargine/lixisenatide) is a prescription drug that’s used to treat type 2 diabetes. Soliqua 100/33 comes as a prefilled single-use pen for injecting the drug under your skin.

Insulin-aspart-szjj is the first rapid-acting insulin biosimilar approved and the third insulin product approved by the FDA.

Lilly/Boehringer Ingelheim's insulin glargine product will be available in a pre-filled pen and cartridges for a reusable pen. The marketing authorisation for the Alliance's insulin glargine ...

the lowest price for Semglee is $27.77 while for Lantus it is $35 for a box of five pens. At least in this community, we would all agree that insulin is affordable, especially compared with 10 ...

Semglee (insulin glargine-yfgn) was approved in 2020 and is injected using a pre-filled pen. It is a synthetic, long-lasting insulin medication used to help manage high blood sugar in adults and ...

NovoFine Autocover 30G disposable safety needles were dispensed for patients enrolled in the pen group. If insulin glargine was prescribed, a vial was dispensed regardless of the treatment group ...

In adults, insulin glargine (a long-acting insulin analog) reduces the risk of nocturnal hypoglycemia and improves control of morning blood glucose levels; however, most published studies included ...

The Tempo pen is currently compatible with three of Lilly's insulin products, including Humalog and Lyumjev, both insulin lispro-based, and insulin glargine brand Basaglar. "Despite technological ...

Sanofi said it would cap a Lantus patient’s monthly out-of-pocket ... According to MSF, data published in JAMA Network Open shows that insulin pens could be produced for as little as $0.94 ...